FDA Inspection
Anshi Pharmaceutical (Zhongshan) Inc.Anshi Pharmaceutical (Zhongshan) Inc. – FDA Inspection, Oct 31, 2012
Record Details
This FDA Inspection record concerns Anshi Pharmaceutical (Zhongshan) Inc., with an inspection on October 31, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 31, 2012
- Product Type
- Drugs
View Company Profile
ID · 5ba36e06-8bcf-46e9-aef1-8c70336d0c9c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 823594
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Anshi Pharmaceutical (Zhongshan) Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Anshi Pharmaceutical (Zhongshan) Inc.
- FDA Inspection 1031944 - 2017-10-27
- FDA Inspection 920920 - 2015-03-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.